首頁 > 市場調查報告書 > 醫療設備

導管泌尿科

市場調查報告書

商品編碼

1378962

2023-2028 年輸尿管支架市場報告（依產品類型、材料、應用、最終用途（醫院和診所、門診手術中心等）和地區）

Ureteral Stents Market Report by Product Type, Material, Application, End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年，全球輸尿管支架市場規模達到3.534億美元。展望未來， IMARC Group預計到2028年市場規模將達到5.041億美元，2022-2028年複合年成長率（CAGR）為6.1%。泌尿系統疾病的日益普及、支架技術的新興技術進步以及鼓勵採用輸尿管支架的政府優惠政策的實施是促進市場成長的一些主要因素。

輸尿管支架是一種由醫用級材料（例如矽膠或聚氨酯）製成的小型軟性管，用於泌尿科治療各種泌尿道疾病。它被插入輸尿管，即連接腎臟和膀胱的管子。它有多種用途，包括緩解阻塞、促進癒合和排水腎臟。它可以緩解腎結石、腫瘤或其他阻塞引起的輸尿管阻塞。它使輸尿管保持開放，使尿液能夠從腎臟自由流入膀胱，從而防止併發症。此外，它是暫時的，需要定期監測和清除，並且在泌尿科護理中至關重要，可確保泌尿系統的健康和功能。

該市場主要由泌尿科技術進步所驅動。此外，更有效和微創的輸尿管支架裝置的開發正在影響市場的成長。此外，現代支架還改善了生物相容性，減少了結垢，並提高了患者的舒適度。因此，醫療保健專業人士更傾向於推薦和使用這些先進的支架，從而推動市場成長。此外，腎結石、泌尿道感染 (UTI) 和輸尿管狹窄等泌尿系統疾病的發生率不斷上升，並且正在加速產品的採用。這些病症通常需要插入輸尿管支架作為治療的一部分。除此之外，易患泌尿系統問題的老年人口不斷增加也促進了市場的成長。同時，人們對泌尿系統疾病及其治療方案的認知不斷提高，導致更早的診斷和干涉，使患者能夠尋求醫療建議和治療，並推動市場成長。

輸尿管支架市場趨勢/促進因素：

泌尿系統疾病的盛行率不斷上升

由於泌尿系統疾病發生率不斷上升，市場受到了重大影響。此外，腎結石數量不斷增加，是一種常見的泌尿系統疾病，其特徵是在腎臟或尿道中形成固體腫塊，阻塞輸尿管，引起劇烈疼痛和潛在的腎臟損害，正在影響市場成長。此外，在這種情況下擴大使用輸尿管支架來緩解阻塞並促進尿流，為患者提供緩解，同時避免更具侵入性的手術，從而促進了市場的成長。此外，不斷成長的老年人口更容易患泌尿系統疾病，包括泌尿道感染、膀胱問題和良性前列腺增生 (BPH)。這些情況可能導致輸尿管阻塞或併發症，需要使用支架進行診斷和治療。此外，對泌尿系統疾病認知的提高和診斷技術的進步導致了早期檢測和干涉，從而加速了產品的採用。

支架領域的新興技術進步

該市場是由顯著的進步和創新推動的，這些進步和創新提高了輸尿管支架的有效性並提高了患者的舒適度和結果。此外，傳統支架通常由不可生物分解的材料製成，需要第二次移除程序。它導致了可生物分解支架的採用，隨著時間的推移，支架逐漸在體內溶解，消除了移除手術的需要，並減少了患者的不適。此外，採用藥物洗脫技術，支架上塗有藥物，可以緩慢釋放到輸尿管中，有助於預防發炎或感染等併發症，從而最大限度地減少副作用並增強支架的治療效果，這是另一個主要的生長誘導因素。除此之外，3D（3D）列印技術的整合改變了支架設計，並允許根據患者獨特的解剖結構創建客製化支架，確保更好的貼合性，減少刺激和不適，加速市場成長。

落實政府優惠政策

鼓勵採用輸尿管支架的政府優惠政策的實施正在影響市場的成長。這些政策正在改善醫療保健的可近性、患者的治療結果和成本效益。此外，政府措施包括宣傳活動和補貼醫療保健計劃，使患者能夠使用支架，從而能夠早期診斷和治療影響市場成長的泌尿系統疾病。此外，多項優惠政策可以為醫療器材產業的研發提供財政誘因和補助，這是另一個主要的成長誘導因素。此外，公司正在投資開發更有效、更舒適和微創的先進支架，這正在促進市場成長。除此之外，政府措施鼓勵新的市場參與者進入市場，產生多種支架選擇，滿足多種患者的需求和偏好，加速市場成長。

輸尿管支架產業細分：

IMARC Group提供了每個細分市場的主要趨勢的分析，以及 2023 年至 2028 年全球、區域和國家層面的預測。我們的報告根據產品類型、材料、應用和最終用途對市場進行了分類。

按產品類型分類：

開口支架

閉端支架

雙J型支架

多環支架

雙J型支架代表最受歡迎的產品類型

該報告根據產品類型對市場進行了詳細的細分和分析。這包括開放式支架、封閉式支架、雙 J 型支架和多環支架。報告顯示，雙J型支架佔據最大的市場佔有率。

雙J型支架又稱雙豬尾支架，是一種專門設計的產品，其形狀獨特，類似字母J，兩端捲曲。此外，雙 J 形支架形狀針對穩定性和功效進行了最佳化，同時捲曲末端充當錨定件，將支架固定在輸尿管內，並影響市場成長。它最大限度地減少了支架可能從其預定位置移動或移位的風險，並確保支架有效地促進尿液從腎臟引流到膀胱，從而防止與輸尿管阻塞相關的併發症。

此外，雙辮子形狀減少了對患者的刺激和不適，提高了患者的舒適度，有助於提高患者的依從性和滿意度，從而促進市場成長。

除此之外，雙 J 型支架也用於臨床場景，從治療腎結石、術後護理到治療輸尿管狹窄，這使其成為面臨多種患者需求的泌尿科醫生和醫療保健提供者的首選。

按材質分類：

金屬輸尿管支架

聚合物輸尿管支架

矽膠支架

聚氨酯支架

混合支架

聚合物輸尿管支架目前佔據最大的市場佔有率

報告還提供了基於材料的詳細市場細分和分析。其中包括金屬輸尿管支架、聚合物輸尿管支架（矽膠支架、聚氨酯支架、混合支架）。報告顯示，聚合物輸尿管支架佔最大的市場佔有率。

聚合物輸尿管支架具有優異的生物相容性，且人體耐受性良好，可最大限度地降低過敏反應或不良組織反應的風險，這使其適合眾多患者，包括對其他材料敏感的患者。

此外，聚合物支架具有高度柔韌性，可以符合輸尿管的自然曲率，使放置過程更加舒適，並降低支架移位或患者不適的風險，從而能夠更好地貼合在尿道內，從而減少了支架植入的機會。刺激或阻塞。

此外，聚合物輸尿管支架有各種尺寸和配置可供選擇，以滿足患者的個別需求，確保泌尿科醫師可以根據患者的解剖結構和特定泌尿系統狀況等因素，為每種情況選擇最合適的支架。

按應用分類：

腎結石

腎臟移植

腫瘤

尿失禁

其他

腎結石是最大的細分市場

報告還提供了基於應用程式的詳細市場細分和分析。這包括腎結石、腎臟移植、腫瘤、尿失禁等。報告稱，腎結石佔據最大的市場佔有率。

腎結石，醫學上稱為腎結石或腎結石，是影響數百萬人的普遍泌尿系統問題。這些小而硬的礦物質和鹽沉積物會在腎臟中形成，當它們進入輸尿管時，會引起劇痛並阻礙尿流。此外，透過將支架插入輸尿管作為導管、保持輸尿管開放、讓結石更舒適地排出來緩解疼痛和促進腎結石排出的產品需求不斷成長，正在影響市場的成長。它可以減輕疼痛，並最大限度地降低併發症的風險，例如與長期阻塞相關的感染或腎臟損傷。

此外，由於飲食習慣、脫水和生活方式選擇而導致腎結石的流行，導致腎結石管理的產品需求不斷增加，促進了市場的成長。

此外，支架技術的進步提高了支架在該應用中的功效，開發了生物可分解支架、藥物洗脫支架和3D列印支架，這些支架對患者更加友好，並且能有效促進腎結石的排出，代表著另一個主要的治療方法。生長誘導因子。

按最終用途細分：

醫院和診所

門診手術中心 (ASC)

其他

醫院和診所主導市場

報告還提供了基於最終用途的詳細市場細分和分析。這包括醫院和診所、門診手術中心 (ASC) 等。報告顯示，醫院和診所佔據了最大的市場。

醫院和診所是泌尿科問題患者的主要照護端。此外，醫院配備了先進的醫療設施和泌尿科專家，能夠提供全面的護理，包括支架的置入和監測，有助於市場的成長。

此外，醫院和診所擁有執行複雜泌尿外科手術的基礎設施和專業知識，例如插入和取出支架，這通常需要醫院和診所可以輕鬆提供的專門設備和訓練有素的醫務人員，這是另一個主要的成長誘導因素。

除此之外，多種支架類型和尺寸的可用性對於滿足患者的多種需求至關重要。醫院和診所通常擁有輸尿管支架的全面庫存，使他們能夠根據每位患者的具體情況和解剖結構選擇最合適的支架。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據輸尿管支架市場大部分

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是最大的市場。

北美市場是由促進創新和研究的完善的醫療保健基礎設施所推動的。它擁有世界知名的醫療機構、研究中心和泌尿外科專家，培養持續改進的文化，從而促進先進技術和治療方法的開發和採用，包括輸尿管支架。

此外，醫療保健提供者對患者護理和舒適度的高度重視，與支架技術的進步相結合，以提高患者的治療效果，這是另一個主要的成長誘導因素。北美的患者可以獲得最新、最先進的醫療治療和設備，包括先進的支架。

同時，北美實施強化的監管框架，確保了包括輸尿管支架在內的醫療器械的安全性和有效性，增強了醫療保健專業人員和患者對市場上現有產品的可靠性和性能的信心，推動了市場成長。

競爭格局：

目前，市場上的主要參與者正在積極實施策略，以鞏固自己的地位並在這個充滿活力的醫療保健領域保持競爭力。這些策略涵蓋各個方面，包括創新、合作夥伴關係、市場擴張和以客戶為中心的方法。他們正在投資研發 (R&D)，以創造下一代產品，包括開發具有先進材料、藥物洗脫功能和改進設計的支架，以提高患者舒適度並減少併發症。具有監控功能的智慧支架等創新也即將出現。此外，一些公司正在與醫療保健提供者、研究機構和學術中心建立戰略夥伴關係和合作，以促進臨床試驗，提供對真實世界患者資料的訪問，並支持基於證據的解決方案的開發。此外，主要參與者正在認知到醫療保健專業人員和患者的重要性，並專注於以客戶為中心的策略，涉及全面的支援服務，包括醫療保健提供者的培訓、患者的教育資源和響應迅速的客戶服務。

市場研究報告對競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

Allium 醫療解決方案有限公司

貝朗梅爾松根股份公司

生物聚合物

波士頓科學公司

貝克頓迪金森公司

康樂保有限公司

庫克集團公司

麥德林工業公司

梅里特醫療系統公司

奧林巴斯公司

泰利福公司

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

本報告回答的關鍵問題

2022年全球輸尿管支架市場規模是多少
2023-2028年全球輸尿管支架市場的預期成長率是多少
COVID-19 對全球輸尿管支架市場有何影響
推動全球輸尿管支架市場的關鍵因素是什麼
根據產品類型，全球輸尿管支架市場的細分如何
全球輸尿管支架市場依材料分類是怎樣的
從應用來看，全球輸尿管支架市場的細分如何
根據最終用途，全球輸尿管支架市場的細分如何
全球輸尿管支架市場的重點區域有哪些
10. 全球輸尿管支架市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

2022年全球輸尿管支架市場規模有多大？
2023-2028年全球輸尿管支架市場的預期成長率是多少？
COVID-19 對全球輸尿管支架市場有何影響？
推動全球輸尿管支架市場的關鍵因素是什麼？
根據產品類型，全球輸尿管支架市場的細分如何？
全球輸尿管支架市場依材料分類是怎樣的？
根據應用，全球輸尿管支架市場的細分如何？
根據最終用途，全球輸尿管支架市場的細分如何？
全球輸尿管支架市場的重點區域有哪些？
全球輸尿管支架市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Allium Medical Solutions Ltd.
- B. Braun Melsungen AG
- Biomerics
- Boston Scientific Corporation
- Becton Dickinson and Company
- Coloplast Ltd.
- Cook Group Incorporated
- Medline Industries Inc.
- Merit Medical Systems Inc.
- Olympus Corporation
- Teleflex Incorporated

簡介目錄圖表

Product Code: SR112023A3827

Abstract

The global ureteral stents market size reached US$ 353.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 504.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2022-2028. The growing prevalence of urological disorders, emerging technological advances in stent technology, and the implementation of favorable government policies encouraging the adoption of ureteral stents are some of the major factors contributing to the market growth.

A ureteral stent is a small, flexible tube produced of medical-grade materials, such as silicone or polyurethane, used in urology to manage various urinary tract conditions. It is inserted into the ureter, the tube connecting the kidney to the bladder. It serves various purposes, including relieving obstruction, facilitating healing, and draining the kidney. It alleviates blockages in the ureter caused by kidney stones, tumors, or other obstructions. It keeps the ureter open, allowing urine to rush freely from the kidney to the bladder, preventing complications. Additionally, it is temporary, requires periodic monitoring and removal, and is essential in urological care, ensuring the health and functionality of the urinary system.

The market is primarily driven by the technological advancements in urology. In addition, the development of more effective and minimally invasive ureteral stent devices is influencing the market growth. Also, modern stents offer improved biocompatibility, reduced encrustation, and enhanced patient comfort. As a result, healthcare professionals are more inclined to recommend and utilize these advanced stents, driving the market growth. Moreover, the rising incidences of urological disorders such as kidney stones, urinary tract infections (UTI), and ureteral strictures are accelerating product adoption. These conditions often require the insertion of ureteral stents as part of their treatment. Besides this, the growing geriatric population susceptible to urological issues contributes to market growth. Along with this, the rising awareness about urological disorders and their treatment options led to earlier diagnosis and intervention, allowing patients to seek medical advice and treatment and propelling the market growth.

Ureteral Stents Market Trends/Drivers:

The growing prevalence of urological disorders

The market has witnessed a significant impact due to the growing incidences of urological disorders. In addition, the increasing number of kidney stones, is a common urological condition characterized by the formation of solid masses in the kidney or urinary tract that obstruct the ureter, causing severe pain and potential kidney damage is influencing the market growth. Also, the increasing use of ureteral stents in such cases to relieve obstruction and promote urine flow, offering patients relief while avoiding more invasive procedures is augmenting the market growth. Moreover, the growing geriatric population is more susceptible to urological disorders, including urinary tract infections, bladder issues, and benign prostatic hyperplasia (BPH). These conditions can lead to ureteral obstructions or complications, requiring the use of stents for diagnostic and therapeutic purposes. Furthermore, the improved awareness of urological disorders and advancements in diagnostic techniques led to early detection and intervention, which is accelerating the product adoption.

The emerging technological advances in stents

The market is driven by significant advancements and innovations improving the effectiveness of ureteral stents and enhancing patient comfort and outcomes. In addition, traditional stents are typically produced from non-biodegradable materials, requiring a second procedure for removal. It led to the adoption of biodegradable stents, gradually dissolving within the body over time, eliminating the need for removal procedures and reducing patient discomfort. Moreover, the incorporation of drug-eluting technology, stents coated with medications that can be slowly released into the ureter, helping to prevent complications such as inflammation or infections which minimizes side effects and enhances the stent's therapeutic effect representing another major growth-inducing factor. Besides this, the integration of three-dimensional (3D) printing technology transforms stent design and allows for the creation of custom-made stents tailored to a patient's unique anatomy which ensures a better fit, reducing irritation and discomfort, accelerating the market growth.

The implementation of favorable government policies

The implementation of favorable government policies encouraging the adoption of ureteral stents is influencing the market growth. These policies are improving healthcare accessibility, patient outcomes, and cost-effectiveness. In addition, government initiatives include awareness campaigns and subsidized healthcare programs, making stents accessible to patients, allowing early diagnosis and treatment of urological conditions which is influencing the market growth. Moreover, several favorable policies can provide financial incentives and grants for research and development (R&D) in the medical device sector, representing another major growth-inducing factor. Also, companies are investing in developing advanced stents that are more effective, comfortable, and minimally invasive, which is augmenting the market growth. Besides this, government initiatives are encouraging new market players to enter the market leading to numerous stent options, catering to several patient needs and preferences, thus accelerating the market growth.

Ureteral Stents Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, material, application and end use.

Breakup by Product Type:

Open End Stents

Closed End Stents

Double J-Stent

Multiloop Stents

Double J-stent represents the most popular product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes open-end stents, closed-end stents, double j-stent, and multiloop stents. According to the report, double j-stent accounted for the largest market share.

The double J-stent, also known as a double-pigtail stent, is a specialized product design characterized by its unique shape, which resembles the letter J with two curled ends. In addition, the double J-stent shape is optimized for stability and efficacy while the curled ends serve as anchors, securing the stent in place within the ureter, and influencing the market growth. It minimizes the risk of migration, where the stent may shift or dislodge from its intended position and ensures that the stent effectively facilitates urine drainage from the kidney to the bladder, preventing complications associated with ureteral obstructions.

Moreover, the double-pigtail shape reduces irritation and discomfort for patients and with improved patient comfort contributes to greater patient compliance and satisfaction, augmenting the market growth.

Besides this, the double J-stent is employed in clinical scenarios, from managing kidney stones and post-operative care to treating ureteral strictures which makes it a preferred choice for urologists and healthcare providers facing several patient needs.

Breakup by Material:

Metallic Ureteral Stents

Polymer Ureteral Stents

Silicone Stents

Polyurethane Stents

Hybrid Stents

Polymer ureteral stents presently account for the largest market share

A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes metallic ureteral stents, polymer ureteral stents (silicone stents, polyurethane stents, and hybrid stents. According to the report, polymer ureteral stents accounted for the largest market share.

Polymer ureteral stents offer excellent biocompatibility and are well-tolerated by the body, minimizing the risk of allergic reactions or adverse tissue responses which makes them suitable for numerous patients, including those with sensitivities to other materials.

Moreover, polymer stents are highly flexible and can conform to the natural curvature of the ureter, allowing for a more comfortable placement procedure and reducing the risk of stent migration or discomfort for the patient which enables a better fit within the urinary tract, reducing the chances of irritation or obstruction.

Additionally, polymer ureteral stents are available in various sizes and configurations to cater to individual patient needs which ensures that urologists can select the most appropriate stent for each case, considering factors including the patient's anatomy and the specific urological condition.

Breakup by Application:

Kidney Stones

Kidney Transplantation

Tumors

Urinary Incontinence

Others

Kidney stones represent the largest market segment

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes kidney stones, kidney transplantation, tumors, urinary incontinence, and others. According to the report, kidney stones accounted for the largest market share.

Kidney stones, medically known as nephrolithiasis or renal calculi, are a widespread urological issue affecting millions of individuals. These small, hard mineral and salt deposits can form in the kidneys and, when they move into the ureter, cause excruciating pain and block urine flow. In addition, the rising product demand for alleviating pain and facilitating the passage of kidney stones by inserting a stent into the ureter to act as a conduit, keeping the ureter open, and allowing the stone to pass more comfortably is influencing the market growth. It reduces pain and minimizes the risk of complications such as infection or kidney damage associated with prolonged blockage.

Additionally, the prevalence of kidney stones due to dietary habits, dehydration, and lifestyle choices is escalating the product demand for kidney stone management, contributing to the market growth.

Moreover, advancements in stent technology improved the efficacy of stents in this application with the development of biodegradable stents, drug-eluting stents, and 3D-printed stents which are more patient-friendly and effective in facilitating the passage of kidney stones, representing another major growth-inducing factor.

Breakup by End Use:

Hospitals and Clinics

Ambulatory Surgical Centers (ASCs)

Others

Hospitals and clinics dominate the market

A detailed breakup and analysis of the market based on the end use has also been provided in the report. This includes hospitals and clinics, ambulatory surgical centers (ASCs), and others. According to the report, hospitals and clinics accounted for the largest market share.

Hospitals and clinics serve as primary points of care for patients with urological issues. In addition, hospitals are equipped with advanced medical facilities and expert urologists, are well-positioned to provide comprehensive care, including the insertion and monitoring of stents, contributing to the market growth.

Moreover, hospitals and clinics have the infrastructure and expertise to perform complex urological procedures, such as the insertion and removal of stents which often require specialized equipment and highly trained medical staff that hospitals and clinics can easily provide, representing another major growth-inducing factor.

Apart from this, the availability of numerous stent types and sizes is essential in addressing several needs of patients. Hospitals and clinics typically maintain a comprehensive inventory of ureteral stents, allowing them to select the most appropriate stent for each patient's specific condition and anatomy.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the majority of ureteral stents market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market.

The North America market is driven by the well-established healthcare infrastructure that promotes innovation and research. It offers world-renowned medical institutions, research centers, and urological experts which fosters a culture of continuous improvement, leading to the development and adoption of advanced technologies and treatments, including ureteral stents.

Moreover, the strong emphasis on patient care and comfort among healthcare providers aligning with the advancements in stent technology to enhance patient outcomes, represents another major growth-inducing factor. Patients in North America have access to the latest and most advanced medical treatments and devices, including advanced stents.

Along with this, North America's implementation of an enhanced regulatory framework ensures the safety and efficacy of medical devices, including ureteral stents, instilling confidence in healthcare professionals and patients regarding the reliability and performance of the products available in the market, propelling the market growth.

Competitive Landscape:

At present, key players in the market are actively implementing strategies to strengthen their positions and remain competitive in this dynamic healthcare segment. These strategies encompass various aspects, including innovation, partnerships, market expansion, and customer-centric approaches. They are investing in research and development (R&D) to create next-generation products including developing stents with advanced materials, drug-eluting capabilities, and improved designs to enhance patient comfort and reduce complications. Innovations such as smart stents with monitoring capabilities are also on the horizon. Moreover, several companies are entering strategic partnerships and collaborations with healthcare providers, research institutions, and academic centers which facilitate clinical trials, provide access to real-world patient data, and support the development of evidence-based solutions. Furthermore, key players are recognizing the importance of healthcare professionals and patients and focusing on customer-centric strategies involving comprehensive support services, including training for healthcare providers, educational resources for patients, and responsive customer service.

The market research report has provided a comprehensive analysis of the competitive landscape . Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Allium Medical Solutions Ltd.

B. Braun Melsungen AG

Biomerics

Boston Scientific Corporation

Becton, Dickinson and Company

Coloplast Ltd.

Cook Group Incorporated

Medline Industries Inc.

Merit Medical Systems Inc.

Olympus Corporation

Teleflex Incorporated

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In June 2022, Boston Scientific Corporation was recognized with a Bronze Edison Award in the Science and Medical category for its Tria Ureteral Stent, which is the first stent produced with a proprietary surface technology developed to offer protection against the accumulation of urine calcium and magnesium salt deposits.

In October 2020, Allium Medical Solutions Ltd., which specializes in minimally invasive technologies offer large markets with innovative solutions for clinical needs, announced that its urological stents received CE Mark for a new indication for treating urethral fistula after a successful trial.

In February 2023, Olympus Corporation, a global medtech company announced the acquisition of Taewoong Medical Co., Ltd, (Taewoong Medical), a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents1 to strengthen its GI EndoTherapy product portfolio capabilities, enhancing patient outcome through comprehensive solutions.

Key Questions Answered in This Report

1. What was the size of the global ureteral stents market in 2022?
2. What is the expected growth rate of the global ureteral stents market during 2023-2028?
3. What has been the impact of COVID-19 on the global ureteral stents market?
4. What are the key factors driving the global ureteral stents market?
5. What is the breakup of the global ureteral stents market based on the product type?
6. What is the breakup of the global ureteral stents market based on the material?
7. What is the breakup of the global ureteral stents market based on the application?
8. What is the breakup of the global ureteral stents market based on the end use?
9. What are the key regions in the global ureteral stents market?
10. Who are the key players/companies in the global ureteral stents market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Ureteral Stents Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Open End Stents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Closed End Stents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Double J-Stents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Multiloop Stents
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Material

7.1 Metallic Ureteral Stents
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Polymer Ureteral Stents
- 7.2.1 Market Trends
- 7.2.2 Major Types
  - 7.2.2.1 Silicone Stents
  - 7.2.2.2 Polyurethane Stents
  - 7.2.2.3 Hybrid Stents
- 7.2.3 Market Forecast

8 Market Breakup by Application

8.1 Kidney Stones
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Kidney Transplantation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Tumors
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Urinary Incontinence
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End Use

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Ambulatory Surgical Centers (ASCs)
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Allium Medical Solutions Ltd.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
- 15.3.2 B. Braun Melsungen AG
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 SWOT Analysis
- 15.3.3 Biomerics
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Boston Scientific Corporation
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Becton Dickinson and Company
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Coloplast Ltd.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Cook Group Incorporated
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Medline Industries Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 SWOT Analysis
- 15.3.9 Merit Medical Systems Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Olympus Corporation
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Teleflex Incorporated
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Ureteral Stents Market: Major Drivers and Challenges
Figure 2: Global: Ureteral Stents Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Ureteral Stents Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Ureteral Stents Market: Breakup by Material (in %), 2022
Figure 6: Global: Ureteral Stents Market: Breakup by Application (in %), 2022
Figure 7: Global: Ureteral Stents Market: Breakup by End Use (in %), 2022
Figure 8: Global: Ureteral Stents Market: Breakup by Region (in %), 2022
Figure 9: Global: Ureteral Stents (Open End Stents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Ureteral Stents (Open End Stents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Ureteral Stents (Closed End Stents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Ureteral Stents (Closed End Stents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Ureteral Stents (Double J-Stents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Ureteral Stents (Double J-Stents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Ureteral Stents (Multiloop Stents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Ureteral Stents (Multiloop Stents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Ureteral Stents (Metallic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Ureteral Stents (Metallic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Ureteral Stents (Polymer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Ureteral Stents (Polymer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Ureteral Stents (Kidney Stones) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Ureteral Stents (Kidney Stones) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Ureteral Stents (Kidney Transplantation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Ureteral Stents (Kidney Transplantation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Ureteral Stents (Tumors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Ureteral Stents (Tumors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Ureteral Stents (Urinary Incontinence) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Ureteral Stents (Urinary Incontinence) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Ureteral Stents (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Ureteral Stents (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Ureteral Stents (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Ureteral Stents (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Ureteral Stents (Ambulatory Surgical Centers-ASCs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Ureteral Stents (Ambulatory Surgical Centers-ASCs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Ureteral Stents (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Ureteral Stents (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia-Pacific: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia-Pacific: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Ureteral Stents Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Ureteral Stents Market: Breakup by Country (in %), 2022
Figure 85: Middle East and Africa: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Global: Ureteral Stents Industry: SWOT Analysis
Figure 87: Global: Ureteral Stents Industry: Value Chain Analysis
Figure 88: Global: Ureteral Stents Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Ureteral Stents Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Ureteral Stents Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Ureteral Stents Market Forecast: Breakup by Material (in Million US$), 2023-2028
Table 4: Global: Ureteral Stents Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Ureteral Stents Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 6: Global: Ureteral Stents Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Ureteral Stents Market: Competitive Structure
Table 8: Global: Ureteral Stents Market: Key Players

02-2729-4219

+886-2-2729-4219